FTSE China A50 index futures opened 0.80% lower, and closed down 0.89% in the last session.The negative spread of 10-year treasury bonds between China and the United States has expanded to more than 250BP, the largest since June 2002.Google reached a strategic cooperation with domestic consumer-grade AR glasses manufacturer XREAL. At the Android XR conference, Google reached a strategic cooperation with domestic consumer-grade AR glasses manufacturer XREAL. XREAL's industrial chain partners include Luxshare and Longqi Technology. Last week, XREAL just released a new generation of XREAL One, which is equipped with XREAL's self-developed space computing chip-X1 for the first time.
Bestak: Actively deploy the C-end smart product business. At present, it has not cooperated with Bean Bag AI. Bestak said at the performance briefing on December 12 that on the one hand, the company actively deployed the C-end smart product business, exerted its own brand, promoted business expansion with category innovation, and continuously enhanced the strategic value of the new development pattern. On the other hand, the company invested in the layout of cross-border e-commerce companies, and joined hands with them to promote the series of inflator products to the sea, strengthen the cross-border e-commerce coordination strategy, and vigorously explore the potential market. In addition, the company said that the company has not cooperated with Bean Bag AI at present.Pacific Securities: The reversal of photovoltaic industry is about to focus on three directions. The Pacific Securities Research Report pointed out that with the continuous breakthrough of new markets and technologies, the new cycle of photovoltaic parity is accelerating, and the reversal of photovoltaic industry is about to begin. It is suggested to focus on three directions: 1) The new cycle of supply and demand is expected to start in 2025, the industry quotation and profit are expected to be restored, and the leading advantages will be gradually highlighted. In 2025, it is expected to usher in a new round of growth, including Longji Green Energy and Jingke Energy. 2) New technology fields with large cost reduction space and continuous technology iteration, such as GCL Technology and Perovskite, are expected to fully benefit; 3) The advantages of supporting facilities and leading enterprises are prominent, and emerging markets are expected to promote the rapid improvement of shipments and profits, and the advantages of leading enterprises will be further enhanced, and enterprises such as Sunshine Power and Foster are expected to fully benefit.The net outflow of the main market exceeded 10 billion.
Chongda Technology: Five measures are taken to deal with the challenges and opportunities of industry development. Chongda Technology (002815) said in the online collective reception day of investors on December 12 that the company's measures to deal with the challenges and opportunities of industry development include: optimizing product structure, continuing to promote the optimization and upgrading of product structure, increasing R&D investment and market expansion in the field of high-end PCB boards, and accelerating the introduction of high-value customers and orders; Improve production efficiency and cost control; Accelerate the pace of capacity expansion, and promote the speed of capacity improvement of Dalian Plant, Zhuhai No.1 Plant and Zhuhai No.2 Plant in an orderly manner; According to market demand, adjust product price strategy in real time to improve profitability; Accelerate the construction of production base in Thailand, actively participate in international competition and cooperation, and enhance the company's visibility and influence in the global PCB market.Hong Kong stock Jingtai Holdings plunged nearly 15%, and the company's 1.464 million restricted shares are expected to circulate freely from today.Guojin Securities: The warm wind of medical policy comes first, then the progress of innovation going out to sea, and then the opportunity of performance reversal. Guojin Securities Research Report said that the core investment opportunities in the pharmaceutical sector in 25 years will revolve around three logics: 1) innovation going out to sea; 2) demand recovery; 3) Policy expectation reversal. At present, the policy warm wind comes first (the medical track policy continues to warm up, and the overall industry expectation is expected to be optimistic); Then, R&D and innovation will go to sea (innovative drug track will continue to make progress, and it will still be the hottest track in the pharmaceutical sector in 2025, especially it is recommended to pay attention to the clinical data reading and commercialization progress of the first-line target, as well as the fluctuation opportunity of the expected difference of the second-line innovative drugs), and then the performance growth rate is expected to bottom out in the first half of 2025 (but it will take time for this improvement in performance growth rate to come. Considering the current industry communication and historical base, it is expected that 4Q24 and 1Q25 should still be cautiously optimistic.)
Strategy guide
12-14
Strategy guide
12-14